Akers Biosciences Inc Market Cap 2012-2019 | AKER
Akers Biosciences Inc market cap history and chart from 2012 to 2019. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Akers Biosciences Inc market cap as of October 21, 2019 is $0.01B.
||Medical Products Manufacturing
Akers Biosciences, Inc. develops, manufactures and supplies rapid, point-of-care screening and testing products. The Company's products primarily includes BreathScan(R), BreathScan PRO(R), METRON(R), VIVO(TM), Heparin/PF4 Antibody Serum Panels(R) and Breath Ketone. Akers Biosciences, Inc. is based in Thorofare, United States.